Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Arch Med Sci ; 18(1): 112-120, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35154532

RESUMO

INTRODUCTION: Elevated hemoglobin (Hb) A2 is an important diagnostic marker for ß-thalassemia carriers. However, diagnosis of cases with borderline Hb A2 may be problematic. We described the molecular characteristics found in a large cohort of Thai subjects with borderline Hb A2. MATERIAL AND METHODS: Examination was done on 21,657 Thai subjects investigated for thalassemia at Khon Kaen University, Thailand. A total of 202 subjects with borderline Hb A2 (3.5-4.0%) were selectively recruited and hematological parameters were recorded. DNA variants in α-, ß-, δ-globin, and Krüppel-like factor 1 (KLF1) genes were examined using PCR. RESULTS: Among 202 subjects, DNA analysis identified carriers of α+-thalassemia (n = 48; 23.8%), ß-thalassemia (n = 22; 10.9%) and KLF1 mutations (n = 48; 23.8%). No molecular defect was observed in the remaining 84 (41.5%) subjects. Interaction of KLF1 and α-thalassemia was observed in 10 cases. Of the 22 ß-thalassemia carriers, five ß+-thalassemia mutations were identified with lower MCV and higher Hb A2. Seven KLF1 mutations were detected in 10 genotypes in subjects with higher MCV and Hb F. No ß0-thalassemia, α-globin gene triplication or δ-globin gene mutation was detected. CONCLUSIONS: A large proportion of subjects with borderline Hb A2 are not ß-thalassemia carriers and for those with ß-thalassemia, only mild ß+-thalassemia mutations were detected. Evaluation of the patients using Hb A2, Hb F and MCV values will help in selecting cases for further molecular analysis. The results should explain the unusual phenotype of the cases and facilitate a thalassemia screening program in the region.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA